Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Nordström

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
BMC Urology|October 5, 2017
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsyTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
Journal of the National Cancer Institute|July 16, 2016
Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy DecisionsTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
The risk of prostate cancer for men on aspirin, statin or antidiabetic medicationsTobias Nordström, Mark Clements, Robert Karlsson, et al.
Prostate Cancer and Prostatic Diseases|December 21, 2017
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancerTobias Nordström, Olof Akre, Markus Aly, et al.
European Urology|July 30, 2013
A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/mlTobias Nordström, Markus Aly, Martin Eklund, et al.
Lakartidningen|April 22, 2024
[Prostate cancer - diagnostics and screening]Rebecka Arnsrud Godtman, Ola Bratt, Tobias Nordström, et al.
European Transport Research Review|April 16, 2024
Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in NorwayLillian Sve Rokseth, Eva Heinen, Espen Aukrust Hauglin, et al.
European Urology|January 15, 2018
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test PotentialPeter Ström, Tobias Nordström, Markus Aly, et al.
BMJ Open|June 16, 2019
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRITobias Nordström, Fredrik Jäderling, Stefan Carlsson, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohortAxel Möller, Henrik Olsson, Henrik Grönberg, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
BMC Urology|October 5, 2017
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsyTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
Journal of the National Cancer Institute|July 16, 2016
Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy DecisionsTobias Nordström, Jan Adolfsson, Henrik Grönberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
The risk of prostate cancer for men on aspirin, statin or antidiabetic medicationsTobias Nordström, Mark Clements, Robert Karlsson, et al.
Prostate Cancer and Prostatic Diseases|December 21, 2017
Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancerTobias Nordström, Olof Akre, Markus Aly, et al.
European Urology|July 30, 2013
A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/mlTobias Nordström, Markus Aly, Martin Eklund, et al.
Lakartidningen|April 22, 2024
[Prostate cancer - diagnostics and screening]Rebecka Arnsrud Godtman, Ola Bratt, Tobias Nordström, et al.
European Transport Research Review|April 16, 2024
Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in NorwayLillian Sve Rokseth, Eva Heinen, Espen Aukrust Hauglin, et al.
European Urology|January 15, 2018
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test PotentialPeter Ström, Tobias Nordström, Markus Aly, et al.
BMJ Open|June 16, 2019
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRITobias Nordström, Fredrik Jäderling, Stefan Carlsson, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohortAxel Möller, Henrik Olsson, Henrik Grönberg, et al.
Pageof 9